Biologic Therapies VIII: The Intersection of Rheumatology and Allied Specialties
Rheumatology – Infectious Disease: Cases with the Masters
Release date: November 11, 2019
Expiration date: November 11, 2021
Estimated Time of Completion: 15 minutes
Description
In the Biologic Therapies VIII: The Intersection of Rheumatology and Allied Specialties online series, an international, multi-disciplinary faculty of experts focuses on interdisciplinary rheumatology by exploring the interface of rheumatology with disciplines such as infectious disease, gastroenterology, neurology, oncology, dermatology, pulmonology, ophthalmology, and wellness.
Rheumatology – Infectious Disease: Cases with the Masters webcast reviews a variety of cases and assesses treatment options for patients.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Leonard H. Calabrese, DO | Abbvie Pharmaceuticals, BMS, Genentech/Roche, Janssen, Novartis | Consulting Teaching and Speaking |
Crescendo | Teaching and Speaking | |
GSK, Horizon Pharma, Pfizer, Regeneron, Sanofi Aventis, UCB | Consulting |
M. Elaine Husni, MD | Abbvie Pharmaceuticals, Amgen, Genzyme/Sanofi, Janssen, Lilly | Consulting Membership on advisory committee or review panels |
Novartis Pharmaceuticals | Consulting Membership on advisory committee or review panels Teaching and Speaking |
|
Pfizer, Inc. | Membership on advisory committee or review panels | |
WebMD | Consulting Teaching and Speaking |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Cassandra Calabrese, DO
Carlos Isada, MD
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:
AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Lilly USA, LLC
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:
AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Crescendo Bioscience, Inc.
Genentech
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Mallinckrodt Pharmaceuticals
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and
Cleveland Clinic's RJ Fasenmyer Center for Clinical Immunology.